Cutaneous calcification is a condition where calcium salt crystals accumulate in the skin and the deeper layers beneath it, creating deposits that can range from small bumps to large, uncomfortable lesions. Treatment aims to reduce pain, prevent complications like ulcers and infections, improve movement and function, and when possible, slow down or stop the formation of new calcium deposits. The approach depends on the type of calcification, its location, and the underlying cause.
Understanding Treatment Goals for Calcium Deposits in the Skin
When calcium builds up in the skin, the main focus of treatment is to help manage symptoms and improve quality of life. Unlike many other skin conditions, cutaneous calcification does not always respond well to a single treatment approach. The calcium deposits themselves are hard and do not dissolve easily, which makes removing them or preventing new ones from forming a significant challenge.[1]
Treatment strategies are chosen based on several factors. These include whether the calcium deposits are causing pain, whether they interfere with movement or daily activities, and whether they are prone to breaking through the skin and becoming infected. Some people have small deposits that cause no symptoms at all, and in these cases, doctors may recommend simply monitoring the condition rather than active treatment.[2]
The type of calcification also matters. Dystrophic calcification, which is the most common form, occurs when there is tissue damage but calcium and phosphorus levels in the blood are normal. This type is often linked to diseases like systemic sclerosis, dermatomyositis, lupus, or mixed connective tissue disease. In these cases, controlling the underlying disease becomes an important part of managing the calcium deposits.[1]
Metastatic calcification occurs when blood levels of calcium or phosphorus are too high, often due to kidney disease or problems with the parathyroid glands. Here, correcting these metabolic imbalances is a key part of treatment. Iatrogenic calcification results from medical procedures or medications that introduce calcium or phosphate into the body. Idiopathic calcification has no clear cause and normal lab values. Finally, calciphylaxis is a serious form that affects blood vessels and is seen in people with kidney failure on dialysis.[1]
Because the mechanisms that cause calcium to deposit in the skin are not completely understood, treatment often involves trial and error. There is no single therapy that works for everyone, and what helps one person may not help another. This is why an individualized approach, guided by a healthcare team, is so important.[3]
Standard Medical Treatments for Cutaneous Calcification
Standard medical treatments for cutaneous calcification focus on using medications to help reduce symptoms, slow the growth of calcium deposits, or in some cases, encourage the body to reabsorb the calcium. It is important to understand that medical therapy for this condition is generally of limited and variable benefit. Not all patients respond, and some may need to try several different drugs before finding one that helps.[2]
Bisphosphonates are a class of drugs commonly used to treat bone diseases like osteoporosis. They work by reducing bone turnover and can inhibit the growth of calcium crystals that form outside the bones. In cutaneous calcification, bisphosphonates like sodium etidronate or pamidronate may help slow the formation of new deposits. However, prolonged treatment is often necessary, and in some cases, these drugs can paradoxically cause blood phosphate levels to rise.[2][11]
One study found that pamidronate showed objectively beneficial effects in approximately half of the cases examined. This suggests that while bisphosphonates can help some people, they are not a guaranteed solution for everyone. Treatment duration can be long, often requiring several months to see results.[11]
Calcium channel blockers, particularly diltiazem, have been used with variable success. Diltiazem is believed to work by blocking the calcium-sodium pump in cells, which may prevent calcium from accumulating in tissues. Some patients have reported improvement after using diltiazem for at least five years, although the response varies widely from person to person.[11][2]
Warfarin, a blood thinner, has shown benefit in some individuals. The exact mechanism is not fully understood, but warfarin may interfere with the process by which calcium binds to proteins in damaged tissue. It is important to note that low-dose warfarin has not been shown to be effective, so proper dosing under medical supervision is critical.[11]
Colchicine and probenecid are two other medications that have been tried. Colchicine is an anti-inflammatory drug often used for gout, while probenecid is a drug that helps the kidneys remove uric acid. Both have been beneficial in some individuals with cutaneous calcification, though the evidence is limited.[2][11]
Corticosteroids, which are powerful anti-inflammatory drugs, may be beneficial when injected directly into the calcium deposits. Their effect comes from reducing inflammation and inhibiting the activity of fibroblasts, which are cells involved in scar tissue formation. Corticosteroids are particularly useful when the deposits are causing local inflammation or pain.[11]
Minocycline, an antibiotic, has shown promise in some studies. In one report, nine patients with cutaneous calcification related to limited systemic sclerosis were treated with minocycline at doses of 50 to 100 milligrams per day. Improvement was noted in eight of the nine patients within one to seven months. While the size of the lesions improved only moderately, ulceration and inflammation were markedly reduced.[11]
For patients with high phosphate levels, especially those with kidney disease, phosphate binders like magnesium or aluminum antacids may be used. These medications work by binding phosphate in the digestive tract, preventing it from being absorbed into the bloodstream. However, in people with kidney problems, these agents can lead to magnesium or aluminum toxicity, so they must be used with caution.[11]
Sodium thiosulfate has emerged as an important treatment option, particularly for calciphylaxis. It can be given intravenously or applied topically. Sodium thiosulfate is believed to work by dissolving calcium deposits and improving blood flow to affected areas. While it has been most studied in calciphylaxis, there are reports of it being effective in other forms of cutaneous calcification as well.[11][2]
When the underlying cause of calcification is an autoimmune disease like dermatomyositis, immunosuppressive therapies may be used. These include drugs like rituximab and tumor necrosis factor (TNF) inhibitors. By controlling the autoimmune disease and reducing tissue damage, these medications may help prevent new calcium deposits from forming.[11]
In cases where calcium deposits cause severe functional impairment, recurrent infections, or intense pain, surgery may be considered. Surgical removal involves cutting out the calcium deposits, but this carries risks. One major concern is that surgical trauma itself can sometimes stimulate the formation of more calcium deposits. For this reason, doctors may recommend removing a small deposit first to see how the body responds before attempting a larger excision.[2][11]
Carbon dioxide laser therapy is another option for removing deposits. This technique uses a focused laser beam to vaporize the calcium. However, like surgery, laser treatment can cause scarring and may stimulate new calcification. In one study, scarring and hyperkeratosis (thickening of the skin) were observed in more than half of patients treated with CO2 laser.[19]
Innovative Approaches Being Tested in Clinical Trials
Research into new treatments for cutaneous calcification is ongoing, although the number of clinical trials specifically focused on this condition is limited. Many of the therapies that are currently being explored are adaptations of treatments used for other diseases, or they are being tested in small, non-randomized studies.
One area of active investigation involves the use of topical and intralesional sodium thiosulfate. This treatment is being studied as a local, minimally invasive alternative to systemic medications or surgery. When applied to the skin or injected directly into a calcium deposit, sodium thiosulfate may help dissolve the calcium without the side effects associated with drugs taken by mouth or intravenously.[19]
In a systematic review of 40 studies including 136 patients, partial or complete remission after using sodium thiosulfate alone was observed in 64 to 81 percent of cases. Topical sodium thiosulfate, which patients can apply themselves, required consistent use over an average of nearly five months, with some people needing treatment for up to two years. Intralesional injections, where the drug is injected directly into the deposit, were particularly effective at reducing pain. In one analysis, the median reduction in pain score was 3 points on a 10-point scale. However, more than 11 percent of patients experienced temporary pain from the injections themselves.[19]
Extracorporeal shock-wave lithotripsy (ESWL) is another innovative approach being tested. ESWL is a technique originally developed to break up kidney stones using focused sound waves. Researchers are now exploring whether it can be used to fragment calcium deposits in the skin. Early results suggest that ESWL can reduce pain associated with calcification, with a median pain score reduction of 3 points. ESWL is non-invasive, meaning it does not require surgery or injections, which makes it an attractive option for some patients.[19]
Laser therapy is also being refined as a treatment option. Different types of lasers can be used depending on the size and location of the calcium deposits. CO2 lasers, for example, have been used to remove microcalcifications, which are very small deposits. In one study, complete remission of microcalcifications was achieved in 57 percent of patients after a single laser procedure. However, as mentioned earlier, laser treatment can cause scarring and skin thickening, which were observed in 56 percent of patients treated with CO2 laser.[19]
Researchers are also exploring the role of intravenous immunoglobulin (IVIg), a treatment that involves infusing antibodies derived from donated blood plasma into a patient’s bloodstream. IVIg is used to treat a variety of autoimmune and inflammatory conditions, and some studies suggest it may help with smaller calcium deposits. The mechanism is not fully understood, but it may work by modulating the immune system and reducing inflammation that contributes to calcification.[6]
Another experimental approach involves the use of myoinositol hexaphosphate, a dietary substance that has been shown in animal studies to inhibit the crystallization of calcium salts. Researchers applied myoinositol hexaphosphate topically to animals with calcinosis cutis and observed a reduction in lesion size. This suggests that it might have potential as a topical treatment for humans, although clinical trials in people are still needed.[11]
In extraordinarily severe cases of calcinosis cutis associated with connective tissue diseases, autologous hematopoietic stem cell transplantation (HSCT) is being considered. This procedure involves collecting a patient’s own stem cells, destroying the existing immune system with chemotherapy, and then reintroducing the stem cells to rebuild a new immune system. HSCT is a high-risk procedure with serious potential complications, but some studies have suggested it may lead to remission of autoimmune diseases and their complications, including calcification. This approach is only considered in the most severe cases where other treatments have failed.[11]
Recurrences of calcium deposits after treatment are generally rare. In the systematic review of 136 patients treated with minimally invasive approaches, only 3 patients (about 2 percent) experienced recurrences within the follow-up period. This is encouraging, although longer-term studies are needed to determine whether these treatments provide lasting benefits.[19]
How Doctors Diagnose and Monitor Cutaneous Calcification
Before treatment can begin, doctors need to confirm the presence of calcium deposits and determine the underlying cause. Diagnosis typically involves a combination of physical examination, laboratory tests, imaging studies, and sometimes a skin biopsy.[2]
During a physical examination, calcium deposits usually appear as firm, whitish or yellowish bumps or nodules on the skin. They can vary greatly in size, from tiny specks to large lumps. In some cases, the deposits may break through the skin and leak a chalky, creamy substance that consists mainly of calcium phosphate with a small amount of calcium carbonate. These open lesions can become infected, adding to the complexity of the condition.[2]
Laboratory tests are performed to check the levels of calcium and phosphorus in the blood. Normal levels suggest dystrophic or idiopathic calcification, while abnormal levels point to metastatic calcification or calciphylaxis. Additional tests may be done to evaluate kidney function, parathyroid hormone levels, and vitamin D levels, as abnormalities in these areas can contribute to calcium imbalances.[2]
Imaging studies are crucial for determining the extent of calcification. Plain X-rays can show calcium deposits in the skin and deeper tissues. CT scans provide more detailed, three-dimensional images and are useful for planning surgical removal if needed. Bone scintigraphy, a type of nuclear scan, can also detect calcification and is sometimes used to assess how widespread the deposits are.[2]
A skin biopsy involves removing a small sample of affected skin for examination under a microscope. On histology, doctors can see granules and deposits of calcium in the dermis, often surrounded by a foreign-body reaction where the immune system has sent giant cells to try to break down the calcium. This microscopic examination confirms the diagnosis and can sometimes provide clues about the underlying cause.[2]
Most Common Treatment Methods
- Medication therapy
- Bisphosphonates like sodium etidronate or pamidronate to inhibit calcium crystal growth, though prolonged treatment is necessary.[2]
- Calcium channel blockers, particularly diltiazem, used over several years with variable success.[11]
- Warfarin as a blood thinner that may interfere with calcium-protein binding in damaged tissue.[11]
- Colchicine and probenecid, which have shown benefit in some individuals.[2]
- Intralesional corticosteroids injected directly into deposits to reduce inflammation.[11]
- Minocycline at 50 to 100 mg per day, which reduced ulceration and inflammation in most patients within one to seven months.[11]
- Sodium thiosulfate given intravenously or applied topically to help dissolve calcium deposits.[11]
- Immunosuppressive therapies like rituximab and TNF inhibitors for autoimmune-related calcification.[11]
- Surgical removal
- Minimally invasive local therapies
- Topical sodium thiosulfate applied by patients themselves over an average of 4.9 months, with partial or complete remission in 64 to 81 percent of cases.[19]
- Intralesional sodium thiosulfate injections that reduce pain but may cause temporary discomfort in more than 11 percent of patients.[19]
- Extracorporeal shock-wave lithotripsy (ESWL) using sound waves to fragment calcium deposits and reduce pain.[19]
- Laser therapy, particularly CO2 laser, which achieved complete remission of microcalcifications in 57 percent of patients after a single procedure, though scarring occurred in 56 percent.[19]



